Cargando…

Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy

Dilated cardiomyopathy (DCM) is a primary cardiomyopathy with high mortality. The aim of the present study was to identify the related genes in DCM. The four expression profiles (GSE17800, GSE21610, GSE42955 and GSE79962) downloaded from the Gene Expression Omnibus (GEO) database were analyzed using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hao, Huo, Junyu, Jiang, Wanying, Shan, Qijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339620/ https://www.ncbi.nlm.nih.gov/pubmed/32626989 http://dx.doi.org/10.3892/mmr.2020.11145

Ejemplares similares

Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis
por: Wang, Zuoxiang, et al.
Publicado: (2022)

Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy
por: Yang, Yujiao, et al.
Publicado: (2022)

The Effect of Renal Denervation on Cardiac Diastolic Function in Patients with Hypertension and Paroxysmal Atrial Fibrillation
por: Xu, Hai, et al.
Publicado: (2022)

Integrated analysis of WGCNA and machine learning identified diagnostic biomarkers in dilated cardiomyopathy with heart failure
por: Zhu, Yihao, et al.
Publicado: (2022)

Identification of cuproptosis-related biomarkers in dilated cardiomyopathy and potential therapeutic prediction of herbal medicines
por: Bian, Rutao, et al.
Publicado: (2023)

Bioinformatics prediction of potential mechanisms and biomarkers underlying dilated cardiomyopathy
por: Liu, Zhou, et al.
Publicado: (2022)

One potential biomarker for teratozoospermia identified by in-depth integrative analysis of multiple microarray data
por: Han, Baoquan, et al.
Publicado: (2021)

Integrated genomic analysis defines molecular subgroups in dilated cardiomyopathy and identifies novel biomarkers based on machine learning methods
por: Ye, Ling-Fang, et al.
Publicado: (2023)

Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy
por: Haas, Jan, et al.
Publicado: (2021)

Identifying the potential transcriptional regulatory network in Hirschsprung disease by integrated analysis of microarray datasets
por: Xu, Wenyao, et al.
Publicado: (2023)

Investigating the role of NPR1 in dilated cardiomyopathy and its potential as a therapeutic target for glucocorticoid therapy
por: Huang, Yaomeng, et al.
Publicado: (2023)

Comparison between renal denervation and metoprolol on the susceptibility of ventricular arrhythmias in rats with myocardial infarction
por: Jiang, Wanying, et al.
Publicado: (2018)

Multiple-model machine learning identifies potential functional genes in dilated cardiomyopathy
por: Zhang, Lin, et al.
Publicado: (2023)

Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy
por: Portokallidou, Konstantina, et al.
Publicado: (2023)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Circulating circRNA as biomarkers for dilated cardiomyopathy etiology
por: Costa, Marina C., et al.
Publicado: (2021)

Integrated bioinformatics analysis for identifying key genes and pathways in female and male patients with dilated cardiomyopathy
por: Zhang, Min, et al.
Publicado: (2023)

The Potential of Metabolism-Related Gene OGDHL as a Biomarker for Myocardial Remodeling in Dilated Cardiomyopathy
por: Tang, Yaohan, et al.
Publicado: (2022)

Circulating miR-489 as a potential new biomarker for idiopathic dilated cardiomyopathy
por: Ishiguro, Tomoya, et al.
Publicado: (2021)

Exploring novel biomarkers in dilated cardiomyopathy‑induced heart failure by integrated analysis and in vitro experiments
por: Zhou, Lei, et al.
Publicado: (2023)

Machine learning and bioinformatics to identify 8 autophagy-related biomarkers and construct gene regulatory networks in dilated cardiomyopathy
por: Zhang, Fengjun, et al.
Publicado: (2022)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Identification of Signature Genes of Dilated Cardiomyopathy Using Integrated Bioinformatics Analysis
por: Wu, Zhimin, et al.
Publicado: (2023)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Exploring potential biomarkers and therapeutic targets of long COVID-associated inflammatory cardiomyopathy
por: Qi, Peng, et al.
Publicado: (2023)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

Dilated cardiomyopathy in childhood
por: Franklin, OM, et al.
Publicado: (2000)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Apoptosis in Dilated Cardiomyopathy
por: Hong, Bum Kee, et al.
Publicado: (2000)

Immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy: a potential therapeutic option*
por: Cavusoglu, Yuksel, et al.
Publicado: (2023)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Integrated Analysis of Hub Genes and miRNAs in Dilated Cardiomyopathy
por: Huang, Kai, et al.
Publicado: (2020)

Identification of Heparan Sulfate in Dilated Cardiomyopathy by Integrated Bioinformatics Analysis
por: Song, Wenyu, et al.
Publicado: (2022)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

CCND1 Overexpression in Idiopathic Dilated Cardiomyopathy: A Promising Biomarker?
por: Dehghani, Khatereh, et al.
Publicado: (2023)

Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity
por: Tan, Chia Yee, et al.
Publicado: (2023)

Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy
por: Zhang, Qingquan, et al.
Publicado: (2022)

Microarray Analysis of Transcriptome of Medulla Identifies Potential Biomarkers for Parkinson's Disease
por: Liao, Xiao-Yang, et al.
Publicado: (2013)

Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses
por: Zhou, Honghua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ellp4tqcvvqkis9qrg5efk54p2